Asuragen & Wave Life Sciences unite for development of HD diagnostics
Category: #health  By Nikita Chaurasia  Date: 2019-11-26
  • share
  • Twitter
  • Facebook
  • LinkedIn

Asuragen & Wave Life Sciences unite for development of HD diagnostics

It has been reported that various industry giants across the medical fraternity have been involved in the mergers and collaborations to develop and commercialize the treatments for distinguished disorders and diseases. In a light of this, Asuragen and Wave Life Sciences have come together to develop diagnostics for Huntington’s disease.

Austin based molecular diagnostic company, Asuragen has partnered with Wave Life Sciences, a clinical stage genetic medicines company, for the commercialization and manufacturing of the companion diagnostics for Huntington’s disease. For the record, Huntington’s disease is a disorder which is caused by an expansion od CAG repeats in the HTT gene. This results in the gradual breakdown of nerve cells in the brain whilst completely weakening the survivor’s physical and mental abilities.

As per reliable sources, the diagnostics which Asuragen would develop is built on the experience gathered by Wave via a single- nucleotide polymorphism phasing methodology. Through this alliance, Wave targets to utilize Asuragen’s market dominant repetitive sequence diagnostic know-how to deliver scalable SNP phasing to aid global Phase 3 development programs and future commercialization globally.

Speaking on the matter, Jaya Gopal, the VP of Bioanalytics, Pharmacology, and Biomarker Development at Wave’s reportedly stated that the company’s unison with Asuragen for companion diagnostic development is a perfect fit owing to its in depth understanding and expertise with complex molecular targets. Asuragen’s expanding presence in the neurogenetics testing market is also an add on for the Wave.

Meanwhile, the President and CEO of Asuragen, Matthew McManus cited that the company was pleased to a part of the novel category of potential therapies to render a positive impact on HD. He further added that developing a companion diagnostic for Wave’s represents the advancement of the latter company’s product portfolio.

Estimates claim that Wave have currently been conducting two Phase clinical trials, PRECISION-HD1 and PRECISION-HD 2, for the patients suffering from HD. These trials are assessing WVE-120101 & WVE-120102 oligonucleotides, which are designed to reduce the mutant HTT mRNA record.
 

Source credit: https://finance.yahoo.com/news/asuragen-partners-wave-life-sciences-130000639.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Nigeria gives green light to N8.64bn fund for Siemens electricity deal
Nigeria gives green light to N8.64bn fund for Siemens electricity deal
By Nikita Chaurasia

Federal Executive Council of Nigeria has reportedly authorized President Mohammadu Buhari’s initiative to release €15.21 million (N8,648,081,465.2) or N1.708 billion in onshore and N6,940,081,465.20 in offshore as counterpart funding for t...

Nike aborts plans for Goodyear factory amid COVID-19 outbreak
Nike aborts plans for Goodyear factory amid COVID-19 outbreak
By Nikita Chaurasia

America-based multinational sports apparel company Nike Inc. has reportedly abandoned its plans to develop soles for its Nike Air shoes in Goodyear plant in Arizona. Sources close to the matter stated that the company had initially planned to start t...

Dawn Aerospace launches reusable & sub-orbital test plane Mk-II Aurora
Dawn Aerospace launches reusable & sub-orbital test plane Mk-II Aurora
By Nikita Chaurasia

Dawn Aerospace, a New Zealand-based company, has reportedly revealed a carbon fiber-based reusable test plane Mk-ll Aurora. Sources close to the matter stated that although the aircraft’s hydrogen peroxide and kerosene-based engine is yet to be...